Shanton, Reveals

Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

Shanton Pharma Singapore New Jersey

View original content:https://www.prnewswire.co.uk/news-releases/shanton-reveals-topline-data-from-phase-2b-study-in-refractory-gout-patients-302413797.html

en | boerse | 67947735 |